MoonLake Immunotherapeutics |
Chief Scientific Officer |
Class A ordinary shares, par value $0.0001 per share |
2.93M |
$161M |
$55.00 |
Feb 28, 2024 |
Indirect |
MoonLake Immunotherapeutics |
Chief Scientific Officer |
Class A ordinary shares, par value $0.0001 per share |
42K |
$2.31M |
$55.00 |
Feb 28, 2024 |
Direct |
MoonLake Immunotherapeutics |
Chief Scientific Officer |
Class C ordinary shares, par value $0.0001 per share |
196K |
|
|
Oct 1, 2023 |
Direct |
MoonLake Immunotherapeutics |
Chief Scientific Officer |
Common shares, par value CHF 0.10 per share, of MoonLake AG |
5.84K |
|
|
Oct 1, 2023 |
Direct |
MoonLake Immunotherapeutics |
Chief Scientific Officer |
Class C ordinary shares, par value $0.0001 per share |
0 |
|
|
Oct 1, 2023 |
Indirect |
MoonLake Immunotherapeutics |
Chief Scientific Officer |
Common shares, par value CHF 0.10 per share, of MoonLake AG |
0 |
|
|
Oct 1, 2023 |
Indirect |